Putin claims Russia has registered the world’s first coronavirus vaccine, says his daughter has taken it...
Public Health Officials Are Quitting or Getting Fired in Throes of Pandemic...
California's public health officer resigns after COVID-19 undercount problem...
Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus...
Trump to order government to buy certain drugs solely from U.S. factories, setting up major shakeup for industry...
Negotiators remain far apart on coronavirus deal as deadline looms
Fauci: Coronavirus task force to examine aerosolized spread...
Azar to visit Taiwan amid tensions with China
CVS Health Hub Construction Back On Track
Providers press White House for executive help on COVID-19 as talks with Congress falter...
Digital health platform Xealth strikes partnership with another big health IT vendor...
VA, Cerner restart $16B EHR overhaul with planned October go-live...
UPDATE: Epic Systems walks back plans requiring thousands of employees to return to work this week...
Buoyed by bailout funds, all major for-profit hospital chains reported increased profits in Q2...
Mass General Brigham expects up to $1.5B drop in patient revenue this year...
Insurers saw sky-high profits in Q2. Now Congress wants to take a look at their finances...
OIG: Medicare overpaid hospitals $267M for post-acute care transfers to home health...
CVS, Salesforce team up to unite return-to-work platforms...
Kaiser's net income more than doubles to $4.5B in Q2...
Business Is Booming for Dialysis Giant Fresenius. It Took a $137M Bailout Anyway...
Emergency department visits continue to lag...
Blue Shield of California teams with Cricket Health on kidney care...
Alignment Healthcare To Enter New Medicare Advantage Markets For 2021...
Oak Street Health goes public with $328 million offering...
Cigna hit with federal lawsuit alleging Medicare Advantage fraud...
Mental health startup Ginger lands $50M backed by Cigna, Kaiser Permanente...
Feds move to block Geisinger hospital acquisition...
Walmart Healthcare Executive to Depart...
You Might Like
CORONAVIRUS
Pandemic hampers reopening of joint replacement gold mine...
Takeda teams up with Novavax to introduce its coronavirus vaccine in Japan...
Becton Dickinson To Ramp Up Rapid Covid-19 Tests To 12 Million A Month
How the U.S. Ceded Control of Drug Supplies to China...
From telehealth visits to digital pharmacies, seniors have ramped up technology use during COVID-19...
Humana's Broussard: Why COVID-19 is making a clear case for Medicare Advantage...
Florida’s Elder-Care Facilities Buckle as Virus Deaths Climb...
Telemedicine is booming — but many people still face huge barriers to virtual care...
CMS expands telehealth coverage in physician fee rule following Trump executive order...
REUTERS: COVID opens new doors for China's gene giant...
As Trump Praises Plasma, Researchers Struggle to Finish Critical Studies...
New York City’s top health official Dr. Oxiris Barbot resigns amid pandemic response...
Epic EHR-linked telehealth skyrockets at Children’s Colorado...
Britain to roll out millions of 90-minute coronavirus tests...
This tiny Texas company is running most of the drive-thru Covid-19 testing in the US...
Boris Johnson pauses England's coronavirus reopening...
Trump urges recovered COVID-19 patients to donate plasma...
FOLLOW HEALTHCARE REPORT ON TWITTER...
JOIN HEALTHCARE REPORT'S DAILY EMAIL LIST HERE...
MARWOOD: The Evolving Landscape of Prescription Digital Therapeutics for Mental Health in the COVID-19 Era...
Moderna Wants to Transform the Body Into a Vaccine-Making Machine...
Moderna reveals it may not hold patent rights for coronavirus vaccine...
Kodak crashes as $765M loan for drug industry pivot put on hold...
Novavax expects it can meet U.S. COVID-19 vaccine demand in 2021, executives say...
Inspired by llamas’ unique antibodies, scientists create a potent anti-coronavirus molecule...
Antibody drugs could be one of the best weapons against Covid-19. But will they matter?
Bayer inks $425M upfront KaNDy buyout to challenge Astellas for menopause market...
Dr. Anthony Fauci says chance of coronavirus vaccine being highly effective is ‘not great’...
CureVac aims to raise up to $245 million in U.S. IPO...
During Covid-19 Pandemic, Biotech IPOs Already Surpass Record...
Phase III readouts spell disaster for Genentech’s lead IBD drug...
Biohaven adds nearly $1B in Nurtec deals with Royalty Pharma, Sixth Street...
Acutus raises $159M in IPO, challenging medtech leaders for cardiac mapping market...
Guardant growth slows in Q2 but still beats expectations...
AbbVie Agrees to Pay $24 Million to Resolve Humira California Lawsuit...
FDA accepts Biogen's application for Alzheimer's drug, decision due by March...
Pfizer CEO: We’ll Know By October Whether Covid-19 Vaccine Works...
Pfizer to help manufacture Gilead's remdesivir...
Gilead says it will be able to make enough remdesivir to meet global coronavirus demand in October...
Best Buy’s health chief to step down, will remain an advisor as company pursues long-term ambitions...
You Might Like
